Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

View source ↗

Summary

This clinical trial evaluates the use of the Hemanext One Hypoxic Red Blood Cell Storage System for transfusion in transfusion-dependent beta-thalassemia patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemanext One Hypoxic Red Blood Cell Storage System

Snippet

Sponsor: University Research Institute for the Study of Genetic & Malignant Disorders in Childhood | Conditions: Transfusion-dependent Beta-Thalassemia, Blood Transfusion | Status: ENROLLING_BY_INVITATION